AD, HEOR
Description
Cornerstone Search Group’s HEOR/Market Access practice has been retained by a profitable, commercial-stage, and publicly-traded rare disease small pharma for a newly-created and remote-based Associate Director, Health Economics & Outcomes Research position that will serve as the Product Lead for a rare disease drug with multiple high unmet need indications to be launched.
This leadership role reports to a personable and highly-skilled Head of HEOR, whom we previously helped our client hire. We know first-hand about this company’s positive work culture from partnering with them to hire multiple professionals into newly-created positions to help them grow. This is a “Best of Both Worlds” opportunity to join a fast-moving, less bureaucratic, smaller company and interact often and closely with senior and execute management to help define the future while at the same time enjoying the stability of working for a publicly-traded, profitable, and commercial stage pharmaceutical company.
In this role, you will bring leadership to the execution of HEOR strategies to support evidence-based decision-making, market access, and product value demonstration. You will be responsible for developing and executing robust HEOR, RWE, Epi, and COA plans that are aligned with medical affairs strategies, clinical development plans, and commercial strategies to support product value propositions and optimize market access. You will actively participate in cross-functional teams (US and ex-US) and need to demonstrate strong scientific leadership and strategic thinking that is both patient-centric and commercially oriented.
Features
4 HIGHLY ATTRACTIVE FEATURES:
(1) Gain Rare / Ultra-Rare Disease Experience: A great opportunity to gain coveted rare and ultra-rare disease experience for a company that has launched both rare and ultra-rare disease drugs. Our client is comfortable hiring an individual who would like to gain rare disease experience as they are more focused on the individual’s HEOR, business, and communication skills as well as EQ.
(2) Remote Work Arrangement: This company has had remote-working arrangements prior to COVID and the hiring manager, who is the Head of HEOR, also works remotely.
(3) Strong Culture: We have partnered with this client previously and have been impressed by their leadership stability (which is very unusual in this day and age) and the collaborative culture they have forged, which has been greatly enjoyed by the people we have helped them hire. They have done an exemplary job of building a management team comprised of team-first, high EQ leaders who are passionate about working in the rare disease sector and enjoy working with each other.
(4) This is a “rare” rare-disease small pharma that has multiple approved drugs, is publicly traded, and is profitable Unlike many small pharmas which are pre-commercial, our client enjoys the stability that comes from having already launched multiple drugs, being profitable, and being publicly-traded.
Responsibilities
Strategic Input:
- Lead the development of HEOR strategy for a first-in-class drug that addresses multiple indications with high unmet need.
- Critically assess the drivers of, and barriers to, reimbursement and market access and drive cross-functional alignment accordingly by providing strategic input into clinical, regulatory, payer/access, marketing and evidence generation strategies and programs. Proactively identify and address key evidence gaps and competitive threats.
- Develop strategies to demonstrate the unmet need with a focus on outcomes that are meaningful to patients, payers, clinical decision-makers, and regulators.
- Provide strategic input into clinical trial design, emphasizing the incorporation of relevant health economic and COA measures.
- Build and maintain strong relationships with key internal (e.g., global cross-functional teams) and external stakeholders (e.g., key opinion leaders, research institutions).
- Develop strategic approaches to communicate product value to stakeholders, including payers, HTA agencies, and clinicians.
Deliverables:
- Plan and manage robust real-world evidence studies, economic models, COAs (PRO and other types) to meet the value evidence needs of health systems, clinicians, payers, HTA/reimbursement agencies, and policymakers.
- Ensure that evidence generation activities are conducted with appropriate scientific rigor and are strategically aligned with cross-functional teams in clin dev, med affairs, market access, reg affairs, etc.
- Develop and validate clinical outcome assessments (COAs), integrating them into clinical trial endpoint hierarchies and aligning with regulatory requirements to support development programs.
- Lead HEOR research projects for multiple indications, including planning, budgeting and execution as well as forging external and internal partnerships.
- Continue to educate yourself and the organization on new scientific and methodological developments within HEOR and the company’s therapeutic areas.
- Oversee the development of publications, posters, and presentations.
- Work with Med Affairs, Market Access, and Marketing to package HEOR evidence for field materials.
Qualifications / Requirements
DESIRED SKILLS, EXPERIENCES & QUALIFICATIONS:
- MS/MPH, PharmD, or PhD with training in a relevant discipline (e.g., economics, epidemiology, health services research, HEOR, statistics, public health, etc.) so that you have a strong knowledge of HEOR methodologies, statistical analysis, and RWE generation.
- 4+ years of relevant experience (HEOR or RWE or Epi) in a pharma/biotech with a track record of designing and leading quality HEOR studies.
- Our client is open to different therapeutic areas of experience. Rare disease experience is only a plus.
- COA / PRO experience is a plus.
- Understanding of both US and global market access and reimbursement landscape is a plus.
- Seeking a proactive and enthusiastic leader with strong communication skills and the ability to manage multiple priorities simultaneously.
- Seeking someone passionate about helping patients in the rare disease and ultra-rare disease communities they focus on.
Contact
Recently Completed Retained Searches by Cornerstone
REPRESENTATIVE RETAINED SEARCH ASSIGNMENTS:- CEO | specialty pharma start-up
- CEO | regenerative medicine start-up
- US CEO | established European small pharma
- CCO | established European Oncology + CNS pharma
- President/US Commercial Head | generics pharma
- CMO | late-stage public biotech
- CMO | mid-size pharma
- CSO | mid-size global biotech
- SVP, Head of Global Medical Affairs | mid-size oncology company
- SVP, Head of Global Clinical Development | multi-TA mid-size pharma
- SVP, Head of Global Regulatory Affairs | late-stage Israeli biotech
- Global Head, Oncology R&D | mid-size European pharma
- Group VP, Global Commercial Head | API Business Unit | Indian pharma
- VP, Data Science RWE | Top 5 Pharma
- VP, Head of Regulatory Affairs | Boston biotech
- VP, US Head of Regulatory Affairs | Top 20 Pharma
- VP, Head of R&D Operations | Boston biotech
- VP, Head of HEOR (Health Economics & Outcomes Research | Top CNS specialty pharma
- VP, Head of US HEOR & RWE | Top 5 Pharma
- VP, Head of Real-World Evidence | Top 5 pharma
- VP, Head of US HEOR | Top Oncology Pharma
- ED, Head of HEOR | Top West Coast Pharma
- VP, Head of Global Market Access | Top Oncology Specialty Pharma
- VP, Head of US Market Access | High-profile late stage biotech
- VP, Head of US Market Access | West Coast Late-Stage Public Biotech
- VP, Head of Heme/Onc Clinical Research | Public oncology biotech
- VP, Head of Clinical Development | late-stage anti-infectives UK pharma
- VP, Head of Global Drug Safety & PV | Chinese oncology biotech
- ED, Head of Clinical Operations | British VC-backed biotech
- ED, Global Commercial Strategy Franchise Head | Top rare disease Boston pharma
- ED, Head of Global Clinical Pharmacology | Public oncology biotech
- ED, Head of Global HEOR | Large US Pharma
- Head, Patient Advocacy | European commercial-stage rare disease biotech
- Medical Directors (Director/SD/ED levels) in Translational Medicine / Clinical Development / Medical Affairs / Drug Safety: 75+ retained assignments
- HEOR/RWE/Market Access (AD/Director/SD/ED levels): 100+ retained assignments
Cornerstone's Privacy Policy
Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.